Related Experiment Video
Updated: Jun 17, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Determinants for HPV vaccine uptake in the Netherlands: A multilevel study
Marc Rondy1, Alies van Lier, Jan van de Kassteele
1National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control, Epidemiology and Surveillance Unit, Bilthoven, The Netherlands. marc.rondy@rivm.nl
Abstract:
In March 2009, a HPV catch-up vaccination campaign was implemented in the Netherlands for girls born between 1993 and 1996. We performed a multilevel study to investigate determinants for HPV vaccination uptake. National coverage for the first dose was 49.9%, with regional uptakes ranging from 31% to 61%. Data was gathered from individual to regional level. Our results suggest that organizing information meetings at schools and communicating with gynaecologists might be beneficial. Lower uptake among various ethnic groups and in areas with higher proportion of voters for Religious Political Parties indicate that communication on HPV vaccine should be adapted to religious and ethnic communities. Furthermore, lower uptake in areas with lower socioeconomic status needs attention since participation to cervical screening is also lower in these areas.
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Criteria for Causality: Bradford Hill Criteria - II
Determinants of Bacterial Pathogenicity and Virulence
Bias in Epidemiological Studies